Dr Reddy’s Strengthens European Position With UK Bevacizumab Launch
The Firm’s Biosimilar To Avastin Is Already Available In Six Other Markets
Dr Reddy’s made a biosimilar debut in the UK with its off-patent version of Roche’s Avastin, which reinforces the company’s “commitment to bring more biosimilar” products to market.
